Pediatrix Medical (MD) Receivables (2009 - 2026)

Pediatrix Medical has disclosed Receivables across 18 years of filings, most recently posting $224.8 million for Q1 2026.

• In Q1 2026, Receivables fell 7.31% year-over-year to $224.8 million; the TTM figure through Mar 2026 stood at $224.8 million (down 7.31% YoY), while the FY2025 annual figure was $229.7 million, down 20.39% from the prior year.
• Receivables declined to $224.8 million in Q1 2026, from $229.7 million in the prior quarter.
• Over the last five years, Receivables for MD reached as high as $1.6 billion in Q4 2022 and fell as low as $224.8 million in Q1 2026.
• The 5-year median for Receivables is $283.7 million (2024), against an average of $693.0 million.
• Annual changes were most pronounced in 2022 — Receivables surged 500.93% — and 2025, when it tumbled 84.27%.
• A 5-year view of Receivables shows it stood at $1.6 billion in 2022, then declined by 11.9% to $1.4 billion in 2023, then plunged by 79.57% to $288.5 million in 2024, then slipped by 20.39% to $229.7 million in 2025, then slipped by 2.12% to $224.8 million in 2026.
• According to Business Quant data, Receivables over the past three periods registered $224.8 million, $229.7 million, and $231.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.